IBI343
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for IBI343, covering 2024-03-20 to 2026-03-19. Get the full timeline:
Most recent: Clinical Trial Update: IBI343 in Combination Therapy for Advanced Malignant Solid Tumors [Phase 2]